Neuphoria Therapeutics annual operating margin
2022
2025
Neuphoria Therapeutics Operating Margin Growth & History (NEUP)
Neuphoria Therapeutics's operating margin was −7.21% for fiscal 2025.
View full Neuphoria Therapeutics company overviewNeuphoria Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-06-30 | −7.21% | — |
| 2022 | 2022-06-30 | −8,095.14% | — |
Neuphoria Therapeutics quarterly operating margin
Q2.25
Q3.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-03-31 | 79.85% | — |
| Q2 2025 | 2024-12-31 | −558.84% | — |
Neuphoria Therapeutics operating margin trends
Between the periods ended 2022-06-30 and 2025-06-30, Neuphoria Therapeutics's operating margin increased from −8,095.14% to −7.21%, a change of +8087.92 percentage points. The latest reported quarter, Q3 2025, shows 79.85%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neuphoria Therapeutics source filings ↗